[1] |
Tang YT, Huang YY, Zheng L, et al. Comparison of isolation methods of exosomes and exosomal RNA from cell culture medium and serum. Int J Mol Med, 2017; 40, 834−44. |
[2] |
Wu MX, Ouyang YS, Wang ZY, et al. Isolation of exosomes from whole blood by integrating acoustics and microfluidics. Proc Natl Acad Sci USA, 2017; 114, 10584−9. |
[3] |
Kalluri R. The biology and function of exosomes in cancer. J Clin Invest, 2016; 126, 1208−15. |
[4] |
Hessvik NP, Llorente A. Current knowledge on exosome biogenesis and release. Cell Mol Life Sci, 2018; 75, 193−208. |
[5] |
Raposo G, Nijman HW, Stoorvogel W, et al. B lymphocytes secrete antigen-presenting vesicles. J Exp Med, 1996; 183, 1161−72. |
[6] |
Street JM, Koritzinsky EH, Glispie DM, et al. Urine exosomes: an emerging trove of biomarkers. Adv Clin Chem, 2017; 78, 103−22. |
[7] |
Samanta S, Rajasingh S, Drosos N, et al. Exosomes: new molecular targets of diseases. Acta Pharmacol Sin, 2018; 39, 501−13. |
[8] |
Ngalame NNO, Luz AL, Makia N, et al. Arsenic alters exosome quantity and cargo to mediate stem cell recruitment into a cancer stem cell-like phenotype. Toxicol Sci, 2018; 165, 40−9. |
[9] |
Poe AJ, Knowlton AA. Exosomes and cardiovascular cell-cell communication. Essays Biochem, 2018; 62, 193−204. |
[10] |
Huber HJ, Holvoet P. Exosomes: emerging roles in communication between blood cells and vascular tissues during atherosclerosis. Curr Opin Lipidol, 2015; 26, 412−9. |
[11] |
Harischandra DS, Ghaisas S, Rokad D, et al. Exosomes in toxicology: relevance to chemical exposure and pathogenesis of environmentally linked diseases. Toxicol Sci, 2017; 158, 3−13. |
[12] |
Moutinho C, Esteller M. MicroRNAs and epigenetics. Adv Cancer Res, 2017; 135, 189−220. |
[13] |
Vaiman D. Genes, epigenetics and miRNA regulation in the placenta. Placenta, 2017; 52, 127−33. |
[14] |
Kim VN. MicroRNA biogenesis: coordinated cropping and dicing. Nat Rev Mol Cell Biol, 2005; 6, 376−85. |
[15] |
Xie LM, Zhang ZW, Tan ZQ, et al. MicroRNA-124 inhibits proliferation and induces apoptosis by directly repressing EZH2 in gastric cancer. Mol Cell Biochem, 2014; 392, 153−9. |
[16] |
Li CL, Deng L, Zhi QM, et al. MicroRNA-183 functions as an oncogene by regulating PDCD4 in gastric cancer. Anticancer Agents Med Chem, 2016; 16, 447−55. |
[17] |
Zhang XY, Chen YF, Zhao P, et al. MicroRNA-19a functions as an oncogene by regulating PTEN/AKT/pAKT pathway in myeloma. Leuk Lymphoma, 2017; 58, 932−40. |
[18] |
Paliouras AR, Monteverde T, Garofalo M. Oncogene-induced regulation of microRNA expression: implications for cancer initiation, progression and therapy. Cancer Lett, 2018; 421, 152−160. |
[19] |
Garofalo M, Quintavalle C, Romano G, et al. miR221/222 in cancer: their role in tumor progression and response to therapy. Curr Mol Med, 2012; 12, 27−33. |
[20] |
Li BL, Lu Y, Yu LH, et al. miR-221/222 promote cancer stem-like cell properties and tumor growth of breast cancer via targeting PTEN and sustained Akt/NF-κB/COX-2 activation. Chem Biol Interact, 2017; 277, 33−42. |
[21] |
Liu SW, Wang YD, Li WG, et al. miR-221-5p acts as an oncogene and predicts worse survival in patients of renal cell cancer. Biomed Pharmacother, 2019; 119, 109406. |
[22] |
Loomis D, Guyton KZ, Grosse Y, et al. Carcinogenicity of benzene. Lancet Oncol, 2017; 18, 1574−5. |
[23] |
Hu DL, Peng XW, Liu YG, et al. Overexpression of miR-221 in peripheral blood lymphocytes in petrol station attendants: a population based cross-sectional study in southern China. Chemosphere, 2016; 149, 8−13. |
[24] |
Jiang R, Huang HY, Lian ZW, et al. Exosomal miR-221 derived from hydroquinone-transformed malignant human bronchial epithelial cells is involved in cell viability of recipient cells. J Appl Toxicol, 2020; 40, 224−33. |
[25] |
Borowicz S, Van Scoyk M, Avasarala S, et al. The soft agar colony formation assay. J Vis Exp, 2014; 92, e51998. |
[26] |
Enguita FJ, Leitao AL. Hydroquinone: environmental pollution, toxicity, and microbial answers. Biomed Res Int, 2013; 542168. |
[27] |
Li JQ, Jiang SF, Chen Y, et al. Benzene metabolite hydroquinone induces apoptosis of bone marrow mononuclear cells through inhibition of β-catenin signaling. Toxicol in Vitro, 2018; 46, 361−9. |
[28] |
Liang BX, Chen YC, Yuan WX, et al. Down-regulation of miRNA-451a and miRNA-486-5p involved in benzene-induced inhibition on erythroid cell differentiation in vitro and in vivo. Arch Toxicol, 2018; 92, 259−72. |
[29] |
Bullock MD, Silva AM, Kanlikilicer-Unaldi P, et al. Exosomal non-coding RNAs: diagnostic, prognostic and therapeutic applications in cancer. Non-Coding RNA, 2015; 1, 53−68. |
[30] |
AnvariFar H, Amirkolaie AK, Miandare HK, et al. Apoptosis in fish: environmental factors and programmed cell death. Cell Tissue Res, 2017; 368, 425−39. |
[31] |
Han WT, Wang S, Jiang LL, et al. Diallyl trisulfide (DATS) suppresses benzene-induced cytopenia by modulating haematopoietic cell apoptosis. Environ Pollut, 2017; 231, 301−10. |
[32] |
Elmore S. Apoptosis: a review of programmed cell death. Toxicol Pathol, 2007; 35, 495−516. |
[33] |
Pistritto G, Trisciuoglio D, Ceci C, et al. Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies. Aging (Albany NY), 2016; 8, 603−19. |
[34] |
Majtnerová P, T Roušar. An overview of apoptosis assays detecting DNA fragmentation. Mol Biol Rep, 2018; 45, 1469−78. |
[35] |
Ray T, Chakrabarti MK, Pal A. Hemagglutinin protease secreted by V. cholerae induced apoptosis in breast cancer cells by ROS mediated intrinsic pathway and regresses tumor growth in mice model. Apoptosis, 2016; 21, 143−54. |
[36] |
Hu XG, Jiang HJ, Jiang XJ. Downregulation of lncRNA ANRIL inhibits proliferation, induces apoptosis, and enhances radiosensitivity in nasopharyngeal carcinoma cells through regulating miR-125a. Cancer Biol Ther, 2017; 18, 331−8. |
[37] |
Sun Y, Li L, Wang L, et al. Body fluids-derived exosomes: paving the novel road to lung cancer diagnosis and therapy. Anticancer Agents Med Chem, 2017; 17, 1734−40. |
[38] |
Lee MS, Jeong MH, Lee HW, et al. PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. Nat Commun, 2015; 6, 7769. |
[39] |
Wang XX, Huang HQ, Young KH. The PTEN tumor suppressor gene and its role in lymphoma pathogenesis. Aging (Albany NY), 2015; 7, 1032−49. |
[40] |
Yuan L, Lv YR, Li HC, et al. Deubiquitylase OTUD3 regulates PTEN stability and suppresses tumorigenesis. Nat Cell Biol, 2015; 17, 1169−81. |
[41] |
Andreas E, Hoelker M, Neuhoff C, et al. MicroRNA 17-92 cluster regulates proliferation and differentiation of bovine granulosa cells by targeting PTEN and BMPR2 genes. Cell Tissue Res, 2016; 366, 219−30. |
[42] |
Garofalo M, Di Leva G, Romano G, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell, 2009; 16, 498−509. |
[43] |
Sarkar S, Dubaybo H, Ali S, et al. Down-regulation of miR-221 inhibits proliferation of pancreatic cancer cells through up-regulation of PTEN, p27(kip1), p57(kip2), and PUMA. Am J Cancer Res, 2013; 3, 465−77. |
[44] |
de Araujo WM, Robbs BK, Bastos LG, et al. PTEN overexpression cooperates with lithium to reduce the malignancy and to increase cell death by apoptosis via PI3K/Akt suppression in colorectal cancer cells. J Cell Biochem, 2016; 117, 458−69. |